Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 795
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 
This article has been cited by
1Experiences of Family Carers for Persons Using Antipsychotic Medication
Paul Morrison,Norman Stomski
Australian and New Zealand Journal of Family Therapy.2017;38(3)498
2A case report of guardian-consent forced paliperidone palmitate for behavioral disturbance due to traumatic brain injury
Amber R. Douglass,Uyen Smyth
Mental Health Clinician.2018;8(3)155
3Early Markers in Resistant Schizophrenia: Effect of the First Antipsychotic Drug
Georgi Panov Panov
4Haloperidol in palliative care: Indications and risks
Iwona Zaporowska-Stachowiak,Katarzyna Stachowiak-Szymczak,Mary-Tiffany Oduah,Maciej Sopata
Biomedicine & Pharmacotherapy.2020;132(4)110772
5Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure
Daria A. Chestnykh,Davide Amato,Johannes Kornhuber,Christian P. Müller
Behavioural Brain Research.2021;403(4)113144
6Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia
Hannah E. Brown,Oliver Freudenreich,Xiaoduo Fan,Stephen O. Heard,Donald Goff,George Petrides,Amy L. Harrington,John M. Kane,Heidi Judge,Bettina Hoeppner,Maurizio Fava,Roy H. Perlis
JAMA Psychiatry.2019;76(7)691
7Differential benefits of olanzapine on executive function in schizophrenia patients: Preliminary findings
Neeti D. Mehta,Michelle J. Won,Shelly L. Babin,Saumil S. Patel,Adel A. Wassef,Alice Z. Chuang,Anne B. Sereno
Human Psychopharmacology: Clinical and Experimental.2020;35(1)691

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal